James Dentzer

Mr. Dentzer is President & CEO of the company. He was appointed to this position in September 2018. Mr. Dentzer, who joined Curis in 2016, was promoted earlier in 2018 to Chief Operating Officer to manage all functions outside of research and development, including business development, manufacturing, quality, human resources, finance, legal, IT and investor and public relations.

Previous experience:
CFO, Dicerna Pharmaceuticals
CFO, Valeritas
CFO, Amicus Therapeutics
VP Corporate Controller, Biogen

MBA, University of Chicago
BA, Boston College

Robert Martell, M.D., Ph.D.

Dr. Martell has served as the company’s Head of Research & Development since 2018. He joined the company as a member of the Board of Directors in 2011.

Previous experience:
Assoc Chief of Hematology/Oncology, Tufts Medical Center                                       
Chief Medical Officer, Tesaro
Chief Medical Officer, MethylGene
Director, Oncology Global Clinical Research, Bristol Myers Squibb
Deputy Director, Medical Science Unit, Bayer

PhD, University of Michigan
MD, Wayne State University 
BA, Kalamazoo College 

Board Certified in Internal Medicine and Medical Oncology